<DOC>
	<DOC>NCT01568593</DOC>
	<brief_summary>Comparison of the efficacy and safety of T2750 and Vismed® in the treatment of moderate to severe Dry Eye Syndrome</brief_summary>
	<brief_title>Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Signed and dated informed consent Male or female aged from ≥ 18 years old. Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study selection. Best far corrected visual acuity &lt; 1/10 Severe blepharitis Severe Dry Eye Eyelid malposition Known hypersensitivity to one of the components of the study medications or test products. Pregnant or breastfeeding woman. Woman of childbearing age (neither menopausal, nor hysterectomised, nor sterilized) not using effective contraception (oral contraceptives, intrauterine device, contraceptive implant or condoms). Inability of patient to understand the study procedures and thus inability to give informed consent. Non compliant patient (e.g. not willing to attend the followup visits, way of life interfering with compliance). Already included once in this study. Patient under guardianship.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>